Ticker: GMTX

Company: Gemini Therapeutics, Inc. /DE

Person: John D Quisel, director, officer

Transaction date: Dec. 19, 2025

Reporting date: Dec. 19, 2025

Average share price: 1.01

Bought 12300.0 shares for 12423.0